Nuvectis Pharma, Inc. (NVCT)
$18.15-7.82%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $482M
- Beta
- -0.24
- P/E (TTM)
- -13.85
- Short % float
- 14.86%
- Days to cover
- 10.3
- SI change
- +6.8%
- 1W
- -9.39%
- 1M
- -22.27%
- vs SPY 1W
- -9.25%
- vs SPY 1M
- -24.78%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on NVCT?
- LOPJLB’s latest quantitative signal on Nuvectis Pharma, Inc. (NVCT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NVCT in?
- Nuvectis Pharma, Inc. (NVCT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Nuvectis Pharma, Inc. (NVCT) do?
- Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug cand…